adenovirus type 4 and type 7 vaccine, live, oral

Vaccineapproved

Approved

Jul 1, 1971

Clinical trial activity

0 trials · 0 clinical orgs · 1 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Timeline

1970s

  1. Jul 1, 1971

    Earliest FDA Approval

2010s

  1. Mar 16, 2011

    Teva — First NDA Organization

  2. Mar 16, 2011

    Teva — NDA Secondary Org

  3. Mar 16, 2011

    Teva — NDA Organization

Indications

Mechanism of action

Approval history

  • approvedJul 1, 1971

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • adenovirus type 4 and type 7 vaccine, live, oral

Organizations

Marketing (2)

OrganizationOrg typeRelationshipDate
TevaFor profitNDA2Mar 16, 2011
TevaFor profitNDAMar 16, 2011